We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medical Mktg | LSE:MMG | London | Ordinary Share | GB0004150685 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.75 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
17/6/2009 20:44 | FailedQS and Tenapen, spot on. As usual, PI screwed. | jonesy100 | |
16/6/2009 11:20 | Another Michael Walters special. | penrynner | |
16/6/2009 08:14 | The Bests should hang their heads in shame.... milking the company for years, producing f#ck all in the way of results, whilst awarding themsleves huge unjustified salaries on the promise of "a deal is imminent" (which was obviously untrue) | failedqs | |
15/6/2009 19:53 | YES the A1 gasbag is certainly no friend of small shareholders. His and no doubt her 'intransigence' puts you off buying shares in small companys. Its not as if they have not made millions of pounds for producing a big fat NOTHING off the back of MMG. | tenapen | |
15/6/2009 19:21 | RNS: MMG downsizing. Best seems determined to have all or nothing. It must be hard to keep this going in the face of such intransigence and I suspect that drug prospects may end up being sold for a pittance to pay the lawyers bills. | shamster | |
13/6/2009 13:06 | Its been a long term holder/supporter from the days it left Ofex that had accumalated stock over the years but started selling when the Bests got booted off by the board and larger shareholders...looks like they've given up on the company from some time ago but as vols very thin only just finished the last lot. | sleepinggiant | |
13/6/2009 08:12 | My presumpion is that, since there has been no news to encourage buyers for a very long time, this thinly-traded stock is subject to stale bulls bailing out on a random basis, putting occasional pressure on the share price. I tried a "fill or kill" buy order at 4.75p, after the 4.5p sale of 180,000 shares was marked, but did not get on. el | el magnifico | |
12/6/2009 20:43 | if it's someone who bought at 4.5p, they did well. | bennytheball | |
12/6/2009 20:26 | I hear a continued seller has been cleared which should hopefully stop the recent down trend. | sleepinggiant | |
11/6/2009 18:57 | ..after a temporary diversion in the other direction | bennytheball | |
08/6/2009 22:55 | el magnifico, great prose. You have a touch of the poet in you. looking forward to 300p. b | bennytheball | |
08/6/2009 22:33 | Quick overview of the bull case: The negatives on MMG are now well over a year old - trashed share price; close-up funding horizon; Bests' outside the tent with big shareholding; continued lack of newsflow; smaller biotech meltdown as the least favoured equity asset class (that one even before the credit crisis showed up!) I guess I'm holding on for a positive surprise. The nice thing is - just one bit of good news should do the trick, given the drip-feed of gloom and doom. Without wishing to lapse into Best-speak : why not a simple, underpriced jv with Big Pharma in either GenVax or ruthenium to shore up finances - and a share price which rises like 2003-2005 (20p to 300p), to boot ? That's the power which equities have to create wealth - but which investors may have forgotten in the wrack and ruin of the credit crisis. el | el magnifico | |
05/6/2009 07:56 | If MMG technology is so desirable then a buyer, partner or possibly investor could seek to settle up with DB if that will take things forward. Perhaps things are not all doom and gloom which is why DB is holding out. We live in hope! | ningram | |
04/6/2009 15:26 | Brinkmanship at this stage is mad - DB or his lawyers are playing a dangerous game. I can imagine any deals on the table being held back by the litigation around his departure. If MMG fail his holding's going to be worth nothing. | bennytheball | |
04/6/2009 15:04 | Did MMI not say that they have kept some money back depending upon the outcome of Best? If they win that dispute then they'll have even more money post the summer.... | sleepinggiant | |
04/6/2009 14:27 | So with a bit of cost control we've bought another couple of months to work out a deal... el m - I wonder if this consitutues the beginning of the "flurry of deadline statements/negotiati the suspense is killing me! | bennytheball | |
04/6/2009 13:43 | FUNDING UPDATE 4 June 2009 - Medical Marketing International Group plc ("MMI" or the "Company") (AIM:MMG), the life sciences company focused on the development of drugs for cancer, today provides an update on the funding arrangements of the Company. At the time of its interim results in December 2008, MMI announced that it was funded until the end of June 2009. Following the advancement of the Company's cost-cutting program, MMI today announces that it now has funds sufficient to last until late summer. The Board continues to discuss further funding options and will provide a further update when appropriate. The Company also reports that it has not yet resolved the outstanding employment claims of David Best. | banjomick | |
02/6/2009 23:54 | Bought back in on a very small scale a few months ago knowing all the history but feel it's going to go one way or the other soon,so worth a 'little' interest on my part. | banjomick | |
02/6/2009 13:04 | Benny, The "silence is golden" thought was directed to MMG's survival and is based on my observation that, typically, companies about to go under do so in a flurry of deadline statements/negotiati Companies negotiating a funding event with the backing of major shareholders or putting to bed a major licensing deal are more likely to be discreet and low profile on the commentary scale. My optimistic guess is that a deal will be done which is (a) low by industry standards, given MMG's poor bargaining position (b) good enough to put a fire under the share price (£4 million market cap right now). That said, this commentary from InVivo blog seems to sum up where we are now: "Is the biotech financing climate warming? As the WSJ pointed out yesterday, big deals such as Sanofi's licensing of Exelixis' PI3 Kinase Inhibitors (see below) and JNJ's acquisition of Cougar Biotech might suggest it's time for more optimism in our industry, as does the good news we report below for Cytokinetics. Still, for a large portion of the sector--notably small cap biotechs whose products or clinical trial data are far from perfect--we suspect the struggles to find financing at a reasonable price continue. Metabasis, a San Diego-based biotech focused on liver and metabolic disease, is a prime example. Unable to get additional funding , the biotech announced on May 27 that it would be reducing headcount by 85% to just 7 employees. Execs at Curagen likely know what remaining staffers at Metabasis are going through. In February the Connecticut company announced it was looking at strategic options; this week comes news of its sale to Celldex Therapeutics (see below). And it's likely there will be more examples in the weeks to come. According to Simos Simeonidis, a senior biotechnology analyst with Rodman & Renshaw, "there are still a number of small-cap companies that will fall victim to the crisis and will either go out of business, merge or be taken over at low valuations." (You can read more about Simeonidis' views of the industry in an upcoming Pink Sheet story, scheduled to appear Monday June 1.)" el | el magnifico | |
01/6/2009 08:27 | el magnifico, why is silence golden? I've also been wondering about parternships and deals as a way forward. MMG market cap looks ridiculously low if one assumes the technology is as promising as ever. Institutional fund raising I assume hard in current circumstances, although maybe I'm wrong there. Maybe institutions are cash rich and scouring for bargains currently? Then again, I wonder if MMG are still out of favour, and/or existing investors are around their limit for holdings in terms of % of the company? So I keep imagining a deal of some sort as the way forward, maybe with Big Pharma, maybe something more of a rabbit out of the hat... What's your money on? b | bennytheball | |
29/5/2009 20:01 | Anyone got the faintest idea what is going on at dear old MMG? The world is abuzz with Big Pharma/Biotech deals, j.v.s, partnerships. If I had to call it, I would guess that silence is golden. We will know soon enough... el | el magnifico | |
22/5/2009 07:22 | MMG will come good and that 5 bed house and a swimming pool in Florida (?) will be yours Benny. The worry would be that the closer MMG get to needing more money the less they have to bargin with !. regards. | tenapen |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions